The Food and Drug Administration has authorized the use of Labcorp's blood-based in-vitro diagnostic test that's works by ...

Nocturnal pulse oximetry indices show limited accuracy in detecting the severity of obstructive sleep apnoea in children with ...

As part of this partnership, Affidea has implemented Skin Analytics’ DERM, an AI medical device software for the automated ...

Seniors experiencing memory problems and cognitive decline now have access to a new diagnostic blood test to detect Alzheimer’s disease. Labcorp this week unveiled the first Food and Drug ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Heart sounds measured on a smartphone app may help clinicians to screen people for atrial fibrillation in community settings, a new study shows.

Discover a study exploring how overactive bladder symptoms can help predict the risk of hypotension after spinal anaesthesia ...

LH launches the first FDA-cleared blood test for Alzheimer's, boosting access to early diagnosis and nudging its stock higher.

A new study suggests the MAGIC Composite Response metric, which combines clinical and biomarker data, improves prediction of ...

An 87-marker Methylation Risk Score predicts heart risk in type 2 diabetes with 84% accuracy when combined with standard health checks.

THE HAGUE, The Netherlands, Aug. 18, 2025, a leading pan-European provider of community-based polyclinics, advanced ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the availability of the Lumipulse® pTau-217/Beta Amyloid 42 Ratio, the first blood-based ...